ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1459

More Severe Mitochondrial Injury at the Time of Diagnosis Is Associated with Poor Prognosis in Minimal Change Disease

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation

Authors

  • Yu, Byung chul, Soonchunhyang University Bucheon Hospital, Bucheon, Korea (the Republic of)
  • Park, Moo Yong, Soonchunhyang University Bucheon Hospital, Bucheon, Korea (the Republic of)
  • Choi, Soo Jeong, Soonchunhyang University Bucheon Hospital, Bucheon, Korea (the Republic of)
  • Hwang, Seung Duk, Soonchunhyang University Bucheon Hospital, Bucheon, Korea (the Republic of)
  • Kim, Jin kuk, Soonchunhyang University Bucheon Hospital, Bucheon, Korea (the Republic of)
Background

We hypothesized that the pathogenesis of minimal change disease (MCD) may be associated with mitochondrial injury and that the degree of mitochondrial injury at the time of diagnosis may serve as a prognostic marker in MCD.

Methods

We retrospectively enrolled patients with MCD who were followed up for more than 5 years and IgA nephropathy (IgAN) patients as controls (n = 20 each). Focusing on the stimulator of interferon genes (STING) pathway activated by mitochondrial injury, immunohistochemical (IHC) staining for STING was performed on kidney tissue at the time of diagnosis. The IHC stain site and signal intensity for STING were analyzed. Time-averaged proteinuria (TA-proteinuria) was calculated as the average of the mean of proteinuria measurements were obtained by 24-hour urine collection every 6 months for each patient. A relapse after treatment was defined as proteinuria >3.5 g per 24 hours after complete or partial remission.

Results

In patients with IgAN and MCD, kidney tissue from 13 patients each showed positive IHC staining for STING. While various kidney structures including glomerulus and tubulointerstitium were stained in IgAN patients, the glomerulus was exclusively stained in MCD patients (Figure). MCD patients were divided into the high (n = 6) and low (n = 14) intensity subgroups according to the signal intensity based on 2+ and more or less, respectively. TA-proteinuria and frequency of relapses during the follow-up period were higher in the high intensity group than in the low intensity group (1.18 ± 0.54 vs. 0.57 ± 0.45 g/day, p = 0.022; and 0.72 ± 0.60 vs 0.09 ± 0.22 episodes/year, p = 0.022, respectively).

Conclusion

These findings suggest that more severe mitochondrial injury, as represented by a high signal intensity of IHC stain for STING at the time of diagnosis, could be used as a prognostic marker to predict poor prognosis in MCD.

IHC staining for STING on kidney tissue obtained from MCD patients (classified into negative (A), 1+ (B), 2+ (C), and 3+ (D) according to the signal intensity) and IgAN patient (E).